Maintelyte

Magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose and sodium acetate trihydrate, the active ingredients in Maintelyte, are an electrolyte solution presented as a sterile intravenous solution for intravenous use. It is employed to restore fluid and electrolyte balance in patients requiring parenteral hydration.

GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, including intensive care units, surgical centres and emergency departments. The company adheres to EU quality standards and provides regulatory support for global distribution.

Maintelyte is an intravenous electrolyte solution used to manage fluid and electrolyte disorders. - Dehydration: restores body water and essential electrolytes in patients unable to take oral fluids. - Hypovolemia: supports circulatory volume in surgical or trauma patients with blood loss. - Electrolyte imbalance: corrects low levels of magnesium, potassium, sodium, and acetate in critical care settings. - Metabolic acidosis: provides acetate which can be metabolized to bicarbonate, helping to buffer acidemia.

Common Side Effects: - Infusion site irritation: mild pain or redness at the catheter site. - Mild hyperkalemia: slight increase in serum potassium levels. - Hypermagnesemia: elevated magnesium causing transient flushing. - Fluid overload: signs of edema or increased blood pressure.

Serious or Rare Side Effects: - Severe hyperkalemia: can precipitate cardiac arrhythmia. - Severe hypermagnesemia: may lead to respiratory depression. - Anaphylactic reaction: sudden rash, bronchospasm, or hypotension. - Electrolyte shift–induced arrhythmia: dangerous heart rhythm changes. - Catheter‑related infection: fever, localized redness, or sepsis.

Before administration, consider the following precautions: - Assess electrolyte levels: check serum magnesium, potassium and sodium. - Monitor cardiac function: observe ECG for arrhythmias during infusion. - Adjust infusion rate: tailor to patient fluid status to avoid overload. - Avoid in severe renal impairment: risk of electrolyte accumulation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Potential drug interactions should be reviewed prior to use. Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: may cause dangerous hyperkalemia. - High‑dose magnesium supplements: risk of severe hypermagnesemia. - Intravenous calcium gluconate: can precipitate with magnesium. Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance potassium retention. - Loop diuretics: may increase electrolyte shifts. - Blood transfusions: can affect calcium and magnesium balance.